This TriMark Publications "Company Business Analysis and Segment Overview" (CBASO) is designed to provide a concise executive summary of a leading company in a particular industry and that company's applicable sector focus. In the process, this CBASO examines the functionality of the Digene's Hybrid Capture System as it relates to improved, early detection of the human papillomavirus (HPV), which is the primary cause of cervical cancer. In addition to its HPV testing products, Digene's diagnostic test products portfolio includes gene-based tests for the detection of chlamydia, gonorrhea, cytomegalovirus, and hepatitis B virus.

1. 1. Introduction Section
2. 1.1 Company Profile
3. 1.2 Products/Business Segments
4. 1.3 Management
5. 1.3.1 Top Executives and Salaries
6. 1.3.2 Board of Directors
8. 2. Analytical Section
9. 2.1 Financial Analysis
10. 2.2 Company's Strategies
11. 2.3 SWOT Analysis
13. 3. Industry/Market Landscape
14. 3.1 Industry Overview
15. 3.1.1 Industry Definition
16. 3.1.2 Industry Key Players
17. 3.2 Company's Outlook on the Industry
18. 3.3 Trends, Issues, Challenges and Opportunities: An Analysis
19. 3.4 Competitive Landscape